Analyst Opinion Summary: Exar Corp. (NYSE:EXAR), Synopsys Inc. (NASDAQ:SNPS)
At the recent close, Exar Corp. (NYSE:EXAR) tinted gains of +2.33% (+0.2 points) to US$8.78. The trading activity of 0.76 Million shares climbed down over an average volume of 291.07K shares. EPS ratio considered by looking at last twelve month figures is -0.33. Over the same time span, the stock notched a high price of US$9.05 and its minimum level reached was US$4.82. The corporation has a market capitalization of US$431.36 Million.
Exar Corp. (NYSE:EXAR)’s earnings per share growth ratio for the past 5 years was noted as 16.3% while revenue increase for the past 5 years was 0.5%. The return on equity ratio or ROE stands at -7.4% while most common profitability ratio return on investment (ROI) was -7.2%. The company’s institutional ownership is monitored at 80.9%. The company’s net profit margin has achieved the current level of -10.7% and possesses 39.4% gross margin.
According to FT, The 4 analysts offering 12 month price targets for Exar Corporation have a median target of 11.75, with a high estimate of 13.00 and a low estimate of 11.00. The median estimate represents a 33.83% increase from the last price of 8.78.
Sell-side Analyst Recommendations
A number of FactSet analysts shared their views about the current stock momentum. The forecast of 4 polled investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts recommended Selling these shares while 0 recommended Hold, according to FactSet data. 0 analysts call it Overweight, while 0 think it is Underweight. Recently, analysts have updated the mean rating to 1.5.
Synopsys Inc. (NASDAQ:SNPS) is valued at US$8.4 Billion and has recently risen 0.88% to US$55.16. The latest trading activity of 0.76 Million shares is below its average volume of 876.82K shares. The trading began at US$55 but the price moved to US$54.69 at one point during the session and finally capitulating to a session high of US$55.17. The stock tapped a 52-week high of US$55.21 while the 12-month Consensus Price Target is US$56.
Currently, the stock carries a price to earnings ratio of 36.82, a price to book ratio of 2.67, and a price to sales ratio of 3.63. For the past 5 years, the company’s revenue has grown 10.2%, while the company’s earnings per share has grown -1.7%. With an institutional ownership near 93.1%, it carries an earnings per share ratio of 1.5.
Financial Times reported that The 7 analysts offering 12 month price targets for Synopsys, Inc. have a median target of 55.00, with a high estimate of 64.00 and a low estimate of 50.00. The median estimate represents a -0.29% decrease from the last price of 55.16.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 6 brokerage firms polled by Factset Research. At present, 2 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 0 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.9.